MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$7,201,014
Prepaid expenses and
other current assets
$856,301
Deferred offering costs
$45,486
Prepaid expenses, net of
current portion
$502,962
Property and equipment,
net
$17,703
Total current assets
$8,102,801
Total noncurrent
assets
$520,665
Total assets
$8,623,466
Total liabilities and
stockholders' equity...
$8,623,466
Total stockholders'
equity (deficit)
$4,522,556
Total liabilities
$4,100,910
Accumulated deficit
-$100,275,268
Additional paid-in capital
$104,797,191
Total current
liabilities
$4,100,910
Common stock, 0.001 par
value, 300,000,000...
$633
Accounts payable and
accrued expenses
$3,772,339
Notes payable
$328,571
Back
Back
Balance Sheet
source: myfinsight.com
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP)